The Seventh Transmembrane Domains of the Delta and Kappa Opioid Receptors Have Different Accessibility Patterns and Interhelical Interactions

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2005 Dec 8

PMID 16331961

Citations 5

Authors

Wei Xu

Mercedes Campillo

Leonardo Pardo

J Kim de Riel

Lee-Yuan Liu-Chen

Affiliations

Soon will be listed here.

Abstract

We applied the substituted cysteine accessibility method (SCAM) to map the residues of the transmembrane helices (TMs) 7 of delta and kappa opioid receptors (deltaOR and kappaOR) that are on the water-accessible surface of the binding-site crevices. A total of 25 consecutive residues (except C7.38) in the TMs 7 were mutated to Cys, one at a time, and each mutant was expressed in HEK 293 cells. Most mutants displayed similar binding affinity for [(3)H]diprenorphine, an antagonist, as the wild types. Pretreatment with (2-aminoethyl)methanethiosulfonate (MTSEA) inhibited [(3)H]diprenorphine binding to eight deltaOR and eight kappaOR mutants. All mutants except deltaOR L7.52(317)C were protected by naloxone from the MTSEA effect, indicating that the side chains of V7.31(296), A7.34(299), I7.39(304), L7.41(306), G7.42(307), P7.50(315), and Y7.53(318) of deltaOR and S7.34(311), F7.37(314), I7.39(316), A7.40(317), L7.41(318), G7.42(319), Y7.43(320), and N7.49(326) of kappaOR are on the water-accessible surface of the binding pockets. Combining the SCAM data with rhodopsin-based molecular models of the receptors led to the following conclusions. (i) The residues of the extracellular portion of TM7 predicted to face TM1 are sensitive to MTSEA in kappaOR but are not in deltaOR. Thus, TM1 may be closer to TM7 in deltaOR than in kappaOR. (ii) MTSEA-sensitive mutants start at position 7.31(296) in deltaOR and at 7.34(311) in kappaOR, suggesting that TM7 in deltaOR may have an additional helical turn (from 7.30 to 7.33). (iii) There is a conserved hydrogen-bond network linking D2.50 of the NLxxxD motif in TM2 with W6.48 of the CWxP motif in TM6. (iv) The NPxxY motif in TM7 interacts with TM2, TM6, and helix 8 to maintain receptors in inactive states. To the best of our knowledge, this represents the first such comparison of the structures of two highly homologous GPCRs.

Citing Articles

Structure and activation of the TSH receptor transmembrane domain.

Miguel R, Sanders J, Furmaniak J, Rees Smith B Auto Immun Highlights. 2016; 8(1):2.

PMID: 27921237 PMC: 5136658. DOI: 10.1007/s13317-016-0090-1.

Differential determinants for coupling of distinct G proteins with the class B secretin receptor.

Garcia G, Dong M, Miller L Am J Physiol Cell Physiol. 2012; 302(8):C1202-12.

PMID: 22277758 PMC: 3330731. DOI: 10.1152/ajpcell.00273.2011.

Visualizing water molecules in transmembrane proteins using radiolytic labeling methods.

Orban T, Gupta S, Palczewski K, Chance M Biochemistry. 2010; 49(5):827-34.

PMID: 20047303 PMC: 2819031. DOI: 10.1021/bi901889t.

Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor.

Yan F, Bikbulatov R, Mocanu V, Dicheva N, Parker C, Wetsel W Biochemistry. 2009; 48(29):6898-908.

PMID: 19555087 PMC: 2752672. DOI: 10.1021/bi900605n.

Dynorphin peptides differentially regulate the human kappa opioid receptor.

Chen Y, Chen C, Liu-Chen L Life Sci. 2007; 80(15):1439-48.

PMID: 17316701 PMC: 2696490. DOI: 10.1016/j.lfs.2007.01.018.

References

Valiquette M, Vu H, Yue S, Wahlestedt C, Walker P . Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands. J Biol Chem. 1996; 271(31):18789-96. DOI: 10.1074/jbc.271.31.18789. View

Fritze O, Filipek S, Kuksa V, Palczewski K, Hofmann K, Ernst O . Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci U S A. 2003; 100(5):2290-5. PMC: 151333. DOI: 10.1073/pnas.0435715100. View

Fukuda K, Kato S, Mori K . Location of regions of the opioid receptor involved in selective agonist binding. J Biol Chem. 1995; 270(12):6702-9. DOI: 10.1074/jbc.270.12.6702. View

Auger-Messier M, Clement M, Lanctot P, Leclerc P, Leduc R, Escher E . The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha. Endocrinology. 2003; 144(12):5277-84. DOI: 10.1210/en.2003-0677. View

Holmgren M, Liu Y, Xu Y, Yellen G . On the use of thiol-modifying agents to determine channel topology. Neuropharmacology. 1996; 35(7):797-804. DOI: 10.1016/0028-3908(96)00129-3. View

Govaerts C, Bondue A, Springael J, Olivella M, Deupi X, Le Poul E . Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J Biol Chem. 2002; 278(3):1892-903. DOI: 10.1074/jbc.M205685200. View

Karlin A, Akabas M . Substituted-cysteine accessibility method. Methods Enzymol. 1998; 293:123-45. DOI: 10.1016/s0076-6879(98)93011-7. View

Javitch J, Ballesteros J, Chen J, Chiappa V, SIMPSON M . Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment. Biochemistry. 1999; 38(25):7961-8. DOI: 10.1021/bi9905314. View

Xue J, Chen C, Zhu J, Kunapuli S, de Riel J, Yu L . The third extracellular loop of the mu opioid receptor is important for agonist selectivity. J Biol Chem. 1995; 270(22):12977-9. View

10.

McPherson G . A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983; 17(1-2):107-13. DOI: 10.1016/0010-468x(83)90031-4. View

11.

Strahs D, Weinstein H . Comparative modeling and molecular dynamics studies of the delta, kappa and mu opioid receptors. Protein Eng. 1998; 10(9):1019-38. DOI: 10.1093/protein/10.9.1019. View

12.

Prioleau C, Visiers I, Ebersole B, Weinstein H, Sealfon S . Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations. J Biol Chem. 2002; 277(39):36577-84. DOI: 10.1074/jbc.M206223200. View

13.

Pepin M, Yue S, Roberts E, Wahlestedt C, Walker P . Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding. J Biol Chem. 1997; 272(14):9260-7. DOI: 10.1074/jbc.272.14.9260. View

14.

Burley S, Petsko G . Aromatic-aromatic interaction: a mechanism of protein structure stabilization. Science. 1985; 229(4708):23-8. DOI: 10.1126/science.3892686. View

15.

Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M . Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1):76-85. DOI: 10.1016/0003-2697(85)90442-7. View

16.

Xu W, Chen C, Huang P, Li J, de Riel J, Javitch J . The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors. Biochemistry. 2000; 39(45):13904-15. DOI: 10.1021/bi001099p. View

17.

Hogue M, Laperriere A, Bhalla S, Walker P, Bouvier M . Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem. 2000; 276(6):4416-23. DOI: 10.1074/jbc.M007151200. View

18.

Wang J, Johnson P, Wu J, Wang W, Uhl G . Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. J Biol Chem. 1994; 269(42):25966-9. View

19.

Xu W, Ozdener F, Li J, Chen C, de Riel J, Weinstein H . Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the mu opioid receptor. FEBS Lett. 1999; 447(2-3):318-24. DOI: 10.1016/s0014-5793(99)00316-6. View

20.

ONeil K, Degrado W . A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science. 1990; 250(4981):646-51. DOI: 10.1126/science.2237415. View